Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Varun Mehra

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Transplantation and Cellular Therapy|August 14, 2023
Myeloablative Dose of Busulfan and Fludarabine Combined with In Vivo T Cell Depletion Is Safe and Effective Conditioning for Acute Myeloid Leukemia and Myelodysplastic Syndrome PatientsDaniele Avenoso, Varun Mehra, Liron Barnea Slonim, et al.
British Journal of Haematology|January 15, 2019
Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survivalAntonio Galleu, Dragana Milojkovic, Simona Deplano, et al.
British Journal of Haematology|August 10, 2019
Comparative analysis of melphalan versus busulphan T-cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute myeloid leukaemiaRob S Sellar, Varun Mehra, Thomas A Fox, et al.
Blood Advances|October 6, 2021
Letermovir prophylaxis in T-cell-depleted transplants: breakthrough and rebound infections in the postmarketing settingMaria A V Marzolini, Varun Mehra, Kirsty J Thomson, et al.
British Journal of Haematology|June 12, 2020
Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experienceVallari Shah, Thinzar Ko Ko, Mark Zuckerman, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 2, 2026
Real-World Utilization Pattern and Outcomes of Letermovir in Adult Cytomegalovirus-Seropositive Allogeneic Hematopoietic Cell Transplant Recipients: An International Retrospective Study From the Infectious Diseases Working Party of EBMTJan Styczynski, Gloria Tridello, Nina Knelange, et al.
Nature Reviews. Neurology|January 15, 2025
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMTPaolo A Muraro, Alice Mariottini, Raffaella Greco, et al.
Leukemia|December 22, 2018
Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophiliaNicholas C P Cross, Yvette Hoade, William J Tapper, et al.
The Lancet. Infectious Diseases|June 20, 2025
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b studyJohan A Maertens, George R Thompson, Andrej Spec, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Transplantation and Cellular Therapy|August 14, 2023
Myeloablative Dose of Busulfan and Fludarabine Combined with In Vivo T Cell Depletion Is Safe and Effective Conditioning for Acute Myeloid Leukemia and Myelodysplastic Syndrome PatientsDaniele Avenoso, Varun Mehra, Liron Barnea Slonim, et al.
British Journal of Haematology|January 15, 2019
Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survivalAntonio Galleu, Dragana Milojkovic, Simona Deplano, et al.
British Journal of Haematology|August 10, 2019
Comparative analysis of melphalan versus busulphan T-cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute myeloid leukaemiaRob S Sellar, Varun Mehra, Thomas A Fox, et al.
Blood Advances|October 6, 2021
Letermovir prophylaxis in T-cell-depleted transplants: breakthrough and rebound infections in the postmarketing settingMaria A V Marzolini, Varun Mehra, Kirsty J Thomson, et al.
British Journal of Haematology|June 12, 2020
Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experienceVallari Shah, Thinzar Ko Ko, Mark Zuckerman, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 2, 2026
Real-World Utilization Pattern and Outcomes of Letermovir in Adult Cytomegalovirus-Seropositive Allogeneic Hematopoietic Cell Transplant Recipients: An International Retrospective Study From the Infectious Diseases Working Party of EBMTJan Styczynski, Gloria Tridello, Nina Knelange, et al.
Nature Reviews. Neurology|January 15, 2025
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMTPaolo A Muraro, Alice Mariottini, Raffaella Greco, et al.
Leukemia|December 22, 2018
Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophiliaNicholas C P Cross, Yvette Hoade, William J Tapper, et al.
The Lancet. Infectious Diseases|June 20, 2025
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b studyJohan A Maertens, George R Thompson, Andrej Spec, et al.
Pageof 5